从诊断到消融时间预测导管消融后房颤复发：系统回顾和荟萃分析

IF 2.3 3区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Clinical Cardiology Pub Date : 2025-06-09 DOI:10.1002/clc.70149

Hala Najeeb, Syeda Farwa Zaidi, Abdul Moeed, Farah Yasmin, Muhamamad Sohaib Asghar, Waqas Ullah, M. Chadi Alraies

{"title":"从诊断到消融时间预测导管消融后房颤复发：系统回顾和荟萃分析","authors":"Hala Najeeb, Syeda Farwa Zaidi, Abdul Moeed, Farah Yasmin, Muhamamad Sohaib Asghar, Waqas Ullah, M. Chadi Alraies","doi":"10.1002/clc.70149","DOIUrl":null,"url":null,"abstract":"<p>A diagnosis-to-ablation time of < 1 year and < 3 years is associated with a significantly lower risk of atrial fibrillation reccurence compared to a time of > 1 year and > 3 years in atrial fibrillation patients awaiting ablation procedures.\n <figure>\n <div><picture>\n <source></source></picture><p></p>\n </div>\n </figure></p>","PeriodicalId":10201,"journal":{"name":"Clinical Cardiology","volume":"48 6","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Diagnosis-to-Ablation Time to Predict the Recurrence of Atrial Fibrillation Following Catheter Ablation: A Systematic Review and Meta-Analysis\",\"authors\":\"Hala Najeeb, Syeda Farwa Zaidi, Abdul Moeed, Farah Yasmin, Muhamamad Sohaib Asghar, Waqas Ullah, M. Chadi Alraies\",\"doi\":\"10.1002/clc.70149\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>A diagnosis-to-ablation time of < 1 year and < 3 years is associated with a significantly lower risk of atrial fibrillation reccurence compared to a time of > 1 year and > 3 years in atrial fibrillation patients awaiting ablation procedures.\\n <figure>\\n <div><picture>\\n <source></source></picture><p></p>\\n </div>\\n </figure></p>\",\"PeriodicalId\":10201,\"journal\":{\"name\":\"Clinical Cardiology\",\"volume\":\"48 6\",\"pages\":\"\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2025-06-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Cardiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/clc.70149\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Cardiology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/clc.70149","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

摘要

从诊断到消融的时间分别为1年和3年，与等待消融的时间分别为1年和3年的房颤患者相比，房颤复发的风险显著降低。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Diagnosis-to-Ablation Time to Predict the Recurrence of Atrial Fibrillation Following Catheter Ablation: A Systematic Review and Meta-Analysis

查看原文本刊更多论文

Diagnosis-to-Ablation Time to Predict the Recurrence of Atrial Fibrillation Following Catheter Ablation: A Systematic Review and Meta-Analysis

A diagnosis-to-ablation time of < 1 year and < 3 years is associated with a significantly lower risk of atrial fibrillation reccurence compared to a time of > 1 year and > 3 years in atrial fibrillation patients awaiting ablation procedures.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Clinical Cardiology 医学-心血管系统

CiteScore

5.10

自引率

3.70%

发文量

189

审稿时长

4-8 weeks

期刊介绍： Clinical Cardiology provides a fully Gold Open Access forum for the publication of original clinical research, as well as brief reviews of diagnostic and therapeutic issues in cardiovascular medicine and cardiovascular surgery. The journal includes Clinical Investigations, Reviews, free standing editorials and commentaries, and bonus online-only content. The journal also publishes supplements, Expert Panel Discussions, sponsored clinical Reviews, Trial Designs, and Quality and Outcomes.